NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Global Health Resources > Global Health at NIH Print

COVID-19 is an emerging, rapidly evolving situation.

COVID-19 public health info from US CDC  |  COVID-19 research info from the US NIH  |  COVID-19 resources for global health researchers


Global Health at NIH

Transmission electron microscope image shows SARS-CoV-2. Courtesy of NIAID-RML.

Coronavirus news and resources for global health researchers

NIH, led by the National Institute of Allergy and Infectious Diseases (NIAID), is working on all aspects of novel coronavirus research, including developing diagnostics, studying potential treatments and producing an effective vaccine.

Coronavirus news and resources

Digital map of Africa. Image by iStock.

NIH launches $58M DS-I Africa program

Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa), a new $58 million NIH Common Fund program, will leverage data and technologies to develop solutions for the continent’s most pressing clinical and public health problems.

NIH DS-I Africa
Young Vietnamese girl with boy toddler strapped to her back, standing in front of wooden house on dry dirt ground.

NIH supports global NCD research, builds capacity

Fogarty and a dozen partners across NIH invested nearly $80 million to establish noncommunicable diseases research partnerships between U.S. and LMIC institutions, and build related research training programs.

NCDs research, training
Woman researcher closely observes samples in dish, many vials of liquid in foreground

NIAID: Global infectious diseases research

National Institute of Allergy and Infectious Diseases (NIAID) research has led to new therapies, vaccines, diagnostic tests and other technologies that have improved the health of millions of people in the U.S. and around the world.

NIAID global research

Recent NIH Global Health News

Updated November 2020